Manage Your Liver
Q:

Liver Fibrosis: Avoiding and preventing the worsening of liver inflammation is the key!

Liver Fibrosis: Avoiding and preventing the worsening of liver inflammation is the key!
A:

Liver fibrosis is a condition that occurs in many chronic liver diseases. It is usually caused by long term inflammation and damage to liver cells. Some of the common causes of liver inflammation are: Chronic hepatitis B/C, fatty liver disease, alcohol abuse, drug toxicity liver damage, etc. Liver fibrosis can be classified into five different levels, denoted as: F0, F1, F2, F3 and F4. F0 means that the liver cells are normal with no fibrotic tissues; a higher number indicates a higher level of fibrosis of the liver, with F4 representing cirrhosis. [1]

 

In Western medicine, liver fibrosis is a consequence of long-term damage to liver cells, it is thought to be a passive and irreversible process. At present, there is no medicine that can directly treat liver fibrosis or cirrhosis. Also, as the fibrotic tissues and damaged liver cells are usually distributed throughout the liver, it is not possible to remove the affected parts of the liver by surgery. 

 

Due to the lack of treatment options, doctors generally recommend patients to improve their lifestyle, or to treat the cause (e.g. chronic hepatitis, fatty liver, NASH) of liver fibrosis, in hopes of slowing down the progression and the worsening of the condition. [2]

 

If liver fibrosis is developed, chronic liver disease patients should be very alert and think twice about treatments they receive, as during the treatment process, the drugs may further damage liver cells and affect liver function due to the toxicity of the drug itself. Therefore, patients with chronic liver disease should focus mainly on stopping inflammation in the liver (by lowering ALT level) and preventing fibrosis. This is the only way to reduce the complications of treatment. 

 

It is important that patients understand that drug treatments can sometimes cause further damage to liver cells, and that they should not take excessive medications; rather they should choose an appropriate and safe means of prevention or treatment.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
liver fibrosiscirrhosischronic inflammationfibrosis
Related Questions
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us